Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085437 (
bacterial meningitis
)
4,038
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A survey of the cerebrospinal fluid (CSF) amino acids, glutamine, and glutamic and gamma-aminobutyric (
GABA
) acids was made in 168 children, aged 1 to 14 years, with various neurological infections. The glutamic acid and glutamine concentrations in the CSF of children with severe forms of acute serous and
bacterial meningitis
were about three to four times as great as in controls. The indices returned almost to normal during recovery.
GABA
is absent in normal CSF, but appeared in the CSF of patients with
bacterial meningitis
. Its determination may be used as an additional test to differentiate between serous and
bacterial meningitis
.
...
PMID:Amino acid composition of cerebrospinal fluid in actue neuroinfections in children. 23 33
Measurement of amino acid levels in the cerebrospinal fluid (CSF) of children with various neurological disorders was performed with high performance liquid chromatography (HPLC). Glutamate increased in patients with
bacterial meningitis
, aseptic meningitis and encephalitis. Aspartate increased in
bacterial meningitis
and seizure disorders. Glycine increased in both bacterial and aseptic meningitis. Taurine increased in
bacterial meningitis
and encephalitis.
GABA
, the main inhibitory amino acid, increased in encephalitis. Excitatory and inhibitory amino acids are richly distributed in brain tissue and are related to neuron activity. Changes in amino acid levels in the CSF may reflect the pathologic state and severity of brain insults, and may be useful in monitoring disease processes. Further study is necessary to determine whether CSF aminos acid levels have a role in practical clinical application.
...
PMID:Excitatory and inhibitory amino acid levels in the cerebrospinal fluids of children with neurological disorders. 1091 May 89